The medication worked for a while, and then it stopped. If you are asking why isn't my GLP-1 working, you are usually not looking for encouragement; you are looking for the checklist a clinician would actually run, and a straight answer about what happens next. That is what this page is. We run it with patients every week inside our medical weight loss program, and the honest summary is this: a plateau on a GLP-1 is almost always explainable, and only sometimes is the explanation the dose.
- A GLP-1 plateau usually has a cause you can check, and the dose is not always it.
- The trials themselves describe plateaus: in SURMOUNT-1, tirzepatide's weight-loss curves flattened over roughly a year and a half.
- Untreated thyroid, insulin and sleep problems are among the most common reasons a working medication stalls.
- Our fee is $299 a month at every dose, so nothing in our practice earns more when your dose goes up.
- The fix starts with labs: fasting insulin, hemoglobin A1c, a full thyroid panel and a complete metabolic panel, drawn quarterly.
The plateau is on the record, in the trials
Start with what the trials say, because it removes the shame from the question. In SURMOUNT-1, the registration trial for tirzepatide, weight loss continued for most of the 72-week study but the curves visibly flattened in the later months; the same shape appears in STEP-1 for semaglutide over its 68 weeks. You can read both papers directly: SURMOUNT-1 in the New England Journal of Medicine and STEP-1.
The point is not that plateaus are guaranteed. It is that a flattening curve is a known feature of the therapy, not a sign that you have failed at it. What the trials do not tell you is why it happened to you, at which dose, and what to do about it. That is a clinical job, and it is the one this page walks through.
The five things we check, in order
When someone tells us the scale has not moved in six or eight weeks, this is the sequence. Not a menu; an order, because the cheap and common explanations come first.
One. Is the dose actually where you think it is
Supply gaps, delayed refills, splitting a pen to make it last, skipping a week and restarting, titrating more slowly than the plan because of nausea: every one of these leaves you taking less than the number on the box. Before anything else, we reconcile what was prescribed with what was actually injected. There is no judgment in it. It is the single most common finding, and it is invisible from the outside.
Two. What you are eating, and what you are keeping down
GLP-1 medications reduce appetite, and the risk that comes with that is not hunger, it is drift. Protein intake falls first, then strength work disappears, then lean mass quietly follows. Less muscle means lower energy expenditure, which means the same medication produces less loss per week. We ask what a typical day of protein looks like and whether resistance training survived the appetite suppression. The fix here is usually adding something, not raising anything.
Three. The markers working against the medication
This is the part a prescription-only program structurally cannot do, because it has no labs. We look at fasting insulin, hemoglobin A1c, a full thyroid panel and a complete metabolic panel. A thyroid that is 'in range' but not right, and insulin resistance that has been rising for years, both blunt how much a GLP-1 can accomplish alone. How doctors use HbA1c to guide weight loss treatment explains why we read these numbers next to each other rather than one at a time.
Four. Sleep, alcohol and the rest of the week
Poor sleep raises appetite through mechanisms the medication does not touch. Alcohol adds calories that are easy to underestimate and slows recovery. Chronic stress does its work through cortisol and through what it does to your decisions at nine at night. None of this is a lecture; it is diagnosis. If the plateau began the month a new job or a new baby arrived, that belongs in the chart.
Five. The side effects you have been managing alone
Nausea you treated by eating less of everything, constipation you treated by skipping doses, fatigue you treated by quitting the gym. Patients manage side effects by reducing the effective dose without ever calling it that, and months later the chart still says the dose they were prescribed, not the dose they take. If you have been quietly managing this on your own, say so plainly. It changes the plan more than almost anything else on this list.
When the honest answer is a higher dose
Sometimes it is. Some people are on a dose that is genuinely too low for their physiology, and the right next step is a controlled titration with a plan and a date to reassess. The difference between that and dose escalation as a business model is the difference between medicine and billing.
A titration decision should come after the checklist above, with labs behind it, with a clinician who can say what a higher dose is expected to change and when you will both look again. If the answer to 'why isn't this working' has always been 'a bigger dose,' with nothing between the question and the answer, the program is not answering it.
One flat fee for the doctor. Zero markup on the medicine.
This is where our structure earns its keep. Our fee is $299 a month whether you are on the starting dose or the top dose, and the medication is billed by your pharmacy at the pharmacy's own price with nothing added by us. There is no molecule upcharge and no dose upcharge, so nothing in our practice earns more when your dose goes up. The structural version of that argument is in Aligned Medicine and the zero-markup model, and the economics of the alternatives are laid out honestly in are telehealth weight loss programs effective.
What the labs say that the scale cannot
Plateau finding
What we check
| Stall began around a dose change | Reconcile prescribed versus taken doses | Correct the schedule before anything else |
|---|---|---|
| Protein and strength work fell away | Intake history, body-composition conversation | Protein target, resistance plan, same dose |
| Thyroid 'normal' but symptoms remain | Full thyroid panel, not TSH alone | Thyroid treatment alongside the GLP-1 |
| Rising fasting insulin or A1c | Fasting insulin, HbA1c, metabolic panel | Insulin-first protocol, medication layering |
| Side effects driving skipped doses | Symptom history, honest dose reconciliation | Slower titration, GI management, same dose |
The panel is the part most programs skip, because labs cost money and the membership model has to be cheap to advertise. We built the fee around them instead. The Biomarker Audit runs every 90 days and is included in the membership: ApoB, Lp(a), hs-CRP, HbA1c, insulin markers, a full hormone and thyroid panel. When the plateau comes, the answer is usually already in the last panel.
What it costs, and what it does not
Two separate charges, and we will not blur them. The clinician is a $598 first charge that covers the first two months, the clinical intake, your first Biomarker Audit and the month that treats, then $299 a month, cancel anytime after the two-month start. The medication is separate, always: prescribed when clinically indicated, filled at the pharmacy you choose, billed by that pharmacy at its own price. Where a branded drug is covered by your insurance, that coverage applies as usual. We set no price, see no margin and take no share on the medicine.
$299 a month is a lot to spend on someone thinking hard about a plateau. The fair comparison is not against $0; it is against what a plateau costs you. A stalled medication at a rising dose on a program with no labs is the exact situation that produced the dose-escalation fees people write to us about. If a clinician cannot accept you into care, the $598 hold is released and you are never charged.
If the medication you are on has never been paired with a panel, our medical weight loss program is where that pairing happens, and the branded-only medication stance is laid out in best GLP-1 medications for weight loss in 2026. We never prescribe compounded GLP-1s, under any circumstance.
FAQ
Why isn't my GLP-1 working anymore? Check, in order: the dose you actually take versus the one prescribed, protein and muscle drift, thyroid and insulin markers, sleep and alcohol, and side effects you have been managing alone. Dose escalation comes last, after the rest is ruled out.
Is a GLP-1 plateau normal? Yes. The trials describe the flattening themselves; SURMOUNT-1's curves level off in the later months of its 72 weeks. It is physiology, not failure.
Should my dose go up when the scale stops moving? Sometimes, but only after a checklist, with labs behind it, and with a date to reassess. A dose that rises because the calendar says so is billing, not medicine.
Can thyroid or insulin problems stall GLP-1 weight loss? They can blunt it. Rising fasting insulin and a thyroid that is 'in range' but not right are two of the most common hidden causes, which is why the plateau workup is a panel, not a conversation about willpower.
What does the membership cost, and does it include the medication? $598 for the first two months, then $299 a month, cancel anytime after. The medication is billed separately by your pharmacy at its own price. The fee covers the clinician and the quarterly Biomarker Audit; it never covers the medicine, and nothing is marked up on it.
Will I have to restart my medication if I switch programs? No. Bring the prescription and any labs you have; the baseline panel is drawn within days and your clinician decides with you what continues and what changes.
Sources
- SURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity, New England Journal of Medicine, 2022 (nejm.org)
- STEP-1: Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021 (nejm.org)